First comprehensive untargeted metabolomics study of suramin-treated Trypanosoma brucei: an integrated data analysis workflow from multifactor data modelling to functional analysis
Mass spectrometry; Metabolomics; Nuclear magnetic resonance; Suramin; Trypanosoma brucei; Animals; Humans; Trypanosoma brucei brucei; Trypanosomiasis, African; Workflow; Endocrinology, Diabetes and Metabolism; Biochemistry; Clinical Biochemistry
Abstract :
[en] Introduction: Human African trypanosomiasis, commonly known as sleeping sickness, is a vector-borne parasitic disease prevalent in sub-Saharan Africa and transmitted by the tsetse fly. Suramin, a medication with a long history of clinical use, has demonstrated varied modes of action against Trypanosoma brucei. This study employs a comprehensive workflow to investigate the metabolic effects of suramin on T. brucei, utilizing a multimodal metabolomics approach. Objectives: The primary aim of this study is to comprehensively analyze the metabolic impact of suramin on T. brucei using a combined liquid chromatography-mass spectrometry (LC–MS) and nuclear magnetic resonance spectroscopy (NMR) approach. Statistical analyses, encompassing multivariate analysis and pathway enrichment analysis, are applied to elucidate significant variations and metabolic changes resulting from suramin treatment. Methods: A detailed methodology involving the integration of high-resolution data from LC–MS and NMR techniques is presented. The study conducts a thorough analysis of metabolite profiles in both suramin-treated and control T. brucei brucei samples. Statistical techniques, including ANOVA-simultaneous component analysis (ASCA), principal component analysis (PCA), ANOVA 2 analysis, and bootstrap tests, are employed to discern the effects of suramin treatment on the metabolomics outcomes. Results: Our investigation reveals substantial differences in metabolic profiles between the control and suramin-treated groups. ASCA and PCA analysis confirm distinct separation between these groups in both MS-negative and NMR analyses. Furthermore, ANOVA 2 analysis and bootstrap tests confirmed the significance of treatment, time, and interaction effects on the metabolomics outcomes. Functional analysis of the data from LC–MS highlighted the impact of treatment on amino-acid, and amino-sugar and nucleotide-sugar metabolism, while time effects were observed on carbon intermediary metabolism (notably glycolysis and di- and tricarboxylic acids of the succinate production pathway and tricarboxylic acid (TCA) cycle). Conclusion: Through the integration of LC–MS and NMR techniques coupled with advanced statistical analyses, this study identifies distinctive metabolic signatures and pathways associated with suramin treatment in T. brucei. These findings contribute to a deeper understanding of the pharmacological impact of suramin and have the potential to inform the development of more efficacious therapeutic strategies against African trypanosomiasis.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Fall, Fanta; Pharmacognosy Research Group, Louvain Drug Research Institute (LDRI), UCLouvain, Brussels, Belgium
Mamede, Lucia; Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium
Vast, Madeline; Institute of Statistics, Biostatistics and Actuarial Sciences (ISBA/LIDAM), Université catholique de Louvain (UCLouvain), Louvain-la-Neuve, Belgium
De Tullio, Pascal ; Université de Liège - ULiège > Département de pharmacie > Chimie pharmaceutique ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Hayette, Marie-Pierre ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Bactériologie, mycologie, parasitologie, virologie et microbiologie ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Michels, Paul A. M.; School of Biological Sciences, The University of Edinburgh, Edinburgh, United Kingdom
Frederich, Michel ; Université de Liège - ULiège > Département de pharmacie > Pharmacognosie ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Govaerts, Bernadette; Institute of Statistics, Biostatistics and Actuarial Sciences (ISBA/LIDAM), Université catholique de Louvain (UCLouvain), Louvain-la-Neuve, Belgium
Quetin-Leclercq, Joëlle; Pharmacognosy Research Group, Louvain Drug Research Institute (LDRI), UCLouvain, Brussels, Belgium
Language :
English
Title :
First comprehensive untargeted metabolomics study of suramin-treated Trypanosoma brucei: an integrated data analysis workflow from multifactor data modelling to functional analysis
R. Adusumilli P. Mallick Data conversion with ProteoWizard msConvert Methods in Molecular Biology (Clifton, N.J.) 2017 1550 339 368 1:CAS:528:DC%2BC1cXht1Oms7jL 10.1007/978-1-4939-6747-6_23 28188540
S. Alsford S. Eckert N. Baker L. Glover A. Sanchez-Flores K.F. Leung D.J. Turner M.C. Field M. Berriman D. Horn High-throughput decoding of antitrypanosomal drug efficacy and resistance Nature 2012 482 7384 232 236 2012Natur.482.232A 1:CAS:528:DC%2BC38Xht1aqtL0%3D 10.1038/nature10771 22278056 3303116
B.M. Bakker P.A.M. Michels F.R. Opperdoes H.V. Westerhoff What controls glycolysis in bloodstream form Trypanosoma brucei? Journal of Biological Chemistry 1999 274 21 14551 14559 1:CAS:528:DyaK1MXks1Krurg%3D 10.1074/jbc.274.21.14551 10329645
Y. Benjamini Y. Hochberg Controlling the false discovery rate: A practical and powerful approach to multiple testing Journal of the Royal Statistical Society: Series B (Methodological) 1995 57 1 289 300 1325392 10.1111/j.2517-6161.1995.tb02031.x
Borchardt, R. T. (2012). Mechanism of drug action: Basic concepts. In Retrometabolic drug design and targeting (8th ed., Vol. 74, pp. 9–38). Wiley.
F. Bringaud D. Baltz T. Baltz Functional and molecular characterization of a glycosomal PPi-dependent enzyme in trypanosomatids: Pyruvate, phosphate dikinase Proceedings of the National Academy of Sciences of the United States of America 1998 95 14 7963 7968 1998PNAS..95.7963B 1:CAS:528:DyaK1cXks1SmtL4%3D 10.1073/pnas.95.14.7963 9653123 20912
D.J. Creek M. Mazet F. Achcar J. Anderson D.-H. Kim R. Kamour P. Morand Y. Millerioux M. Biran E.J. Kerkhoven A. Chokkathukalam S.K. Weidt K.E.V. Burgess R. Breitling D.G. Watson F. Bringaud M.P. Barrett Probing the metabolic network in bloodstream-form Trypanosoma brucei using untargeted metabolomics with stable isotope labelled glucose PLoS Pathogens 2015 10.1371/journal.ppat.1004689 26042734 4456406
F. Fall L. Mamede L. Schioppa A. Ledoux P. De Tullio P. Michels M. Frédérich J. Quetin-Leclercq Trypanosoma brucei: Metabolomics for analysis of cellular metabolism and drug discovery Metabolomics 2022 18 4 20 1:CAS:528:DC%2BB38XhtFWiurzK 10.1007/s11306-022-01880-0 35305174
F. Giacomoni G. Le Corguillé M. Monsoor M. Landi P. Pericard M. Pétéra C. Duperier M. Tremblay-Franco J.-F. Martin D. Jacob S. Goulitquer E.A. Thévenot C. Caron Workflow4Metabolomics: A collaborative research infrastructure for computational metabolomics Bioinformatics 2015 31 9 1493 1495 1:CAS:528:DC%2BC28XhtFyltLfE 10.1093/bioinformatics/btu813 25527831
V. Hannaert Sleeping sickness pathogen (Trypanosoma brucei) and natural products: Therapeutic targets and screening systems Planta Medica 2011 77 6 586 597 1:CAS:528:DC%2BC3MXms1WlsL8%3D 10.1055/s-0030-1250411 20945274
H. Hirumi K. Hirumi Axenic culture of African trypanosome bloodstream forms Parasitology Today 1994 10 2 80 84 1:STN:280:DC%2BD2cznsVKktQ%3D%3D 10.1016/0169-4758(94)90402-2 15275508
J.J. Jansen H.C.J. Hoefsloot J. Van der Greef M.E. Timmerman A.K. Smilde ASCA: Analysis of multivariate data obtained from an experimental design Journal of Chemometrics 2005 19 9 469 481 1:CAS:528:DC%2BD28XjsFClt7g%3D 10.1002/cem.952
Kazakova, R. R., & Masson, P. (n.d.). Quantitative Measurements of Pharmacological and Toxicological Activity of Molecules. Chemestry, 4 (4), 1466–1474. https://doi.org/10.3390/chemistry4040097
V. Kushwaha N. Capalash Aminoacyl-tRNA synthetase (AARS) as an attractive drug target in neglected tropical trypanosomatid diseases-Leishmaniasis, Human African Trypanosomiasis and Chagas disease Molecular and Biochemical Parasitology 2022 251 111510 1:CAS:528:DC%2BB38XitF2rtLrP 10.1016/j.molbiopara.2022.111510 35988745
S. Li Y. Park S. Duraisingham F.H. Strobel N. Khan Q.A. Soltow D.P. Jones B. Pulendran Predicting network activity from high throughput metabolomics PLoS Computational Biology 2013 9 7 e1003123 2013PLSCB..9E3123L 1:CAS:528:DC%2BC3sXht1ygu7nF 10.1371/journal.pcbi.1003123 23861661 3701697
L. Marchese J.F. de Nascimento F.S. Damasceno F. Bringaud P.A.M. Michels A.M. Silber The Uptake and metabolism of amino acids, and their unique role in the biology of pathogenic trypanosomatids Pathogens 2018 7 2 36 1:CAS:528:DC%2BC1MXhsVahurnO 10.3390/pathogens7020036 29614775 6027508
M. Mazet P. Morand M. Biran G. Bouyssou P. Courtois S. Daulouède Y. Millerioux J.-M. Franconi P. Vincendeau P. Moreau F. Bringaud Revisiting the central metabolism of the bloodstream forms of Trypanosoma brucei: Production of acetate in the mitochondrion is essential for parasite viability PLoS Neglected Tropical Diseases 2013 7 12 e2587 1:CAS:528:DC%2BC2cXhtlKlurfJ 10.1371/journal.pntd.0002587 24367711 3868518
P.A.M. Michels M. Gualdrón-López Biogenesis and metabolic homeostasis of trypanosomatid glycosomes: New insights and new questions The Journal of Eukaryotic Microbiology 2022 69 6 e12897 1:CAS:528:DC%2BB38Xht1egtbzL 10.1111/jeu.12897 35175680
P.A.M. Michels O. Villafraz E. Pineda M.B. Alencar A.J. Cáceres A.M. Silber F. Bringaud Carbohydrate metabolism in trypanosomatids: New insights revealing novel complexity, diversity and species-unique features Experimental Parasitology 2021 224 108102 1:CAS:528:DC%2BB3MXhtlKrsLvF 10.1016/j.exppara.2021.108102 33775649
O. Misset O.J. Bos F.R. Opperdoes Glycolytic enzymes of Trypanosoma brucei. Simultaneous purification, intraglycosomal concentrations and physical properties European Journal of Biochemistry 1986 157 2 441 453 1:CAS:528:DyaL28XksFKktro%3D 10.1111/j.1432-1033.1986.tb09687.x 2940090
H.P. Morgan W. Zhong I.W. McNae P.A.M. Michels L.A. Fothergill-Gilmore M.D. Walkinshaw Structures of pyruvate kinases display evolutionarily divergent allosteric strategies Royal Society Open Science 2014 1 1 140120 2014RSOS..140120M 1:CAS:528:DC%2BC2MXhtlKls7jI 10.1098/rsos.140120 26064527 4448766
Z. Nare T. Moses K. Burgess A. Schnaufer M.D. Walkinshaw P.A.M. Michels Metabolic insights into phosphofructokinase inhibition in bloodstream-form trypanosomes Frontiers in Cellular and Infection Microbiology 2023 13 1129791 1:CAS:528:DC%2BB3sXhtFCqtrzK 10.3389/fcimb.2023.1129791 36864883 9971811
J.F. Nascimento R.O.O. Souza M.B. Alencar S. Marsiccobetre A.M. Murillo F.S. Damasceno R.B.M.M. Girard L. Marchese L.A. Luévano-Martinez R.W. Achjian J.R. Haanstra P.A.M. Michels A.M. Silber How much (ATP) does it cost to build a trypanosome? A theoretical study on the quantity of ATP needed to maintain and duplicate a bloodstream-form Trypanosoma brucei cell PLoS Pathogens 2023 19 7 e1011522 1:CAS:528:DC%2BB3sXhs1ylsbbM 10.1371/journal.ppat.1011522 37498954 10409291
F. Nasim I.A. Qureshi Aminoacyl tRNA synthetases: Implications of structural biology in drug development against trypanosomatid parasites ACS Omega 2023 8 17 14884 14899 1:CAS:528:DC%2BB3sXntFeitL4%3D 10.1021/acsomega.3c00826 37151504 10157851
NMR-based Metabolomics. (2018). The Royal Society of Chemistry. https://doi.org/10.1039/9781782627937
F.R. Opperdoes P. Borst Localization of nine glycolytic enzymes in a microbody-like organelle in Trypanosoma brucei: The glycosome FEBS Letters 1977 80 2 360 364 1:CAS:528:DyaE2sXltlSit7w%3D 10.1016/0014-5793(77)80476-6 142663
Z. Pang J. Chong S. Li J. Xia MetaboAnalystR 3.0: Toward an optimized workflow for global metabolomics Metabolites 2020 10 5 186 1:CAS:528:DC%2BB3cXhtFyjtLnI 10.3390/metabo10050186 32392884 7281575
Z. Pang J. Chong G. Zhou D.A. de Lima Morais L. Chang M. Barrette C. Gauthier P.-É. Jacques S. Li J. Xia MetaboAnalyst 5.0: Narrowing the gap between raw spectra and functional insights Nucleic Acids Research 2021 49 1 W388 W396 1:CAS:528:DC%2BB3MXhvFWgtb3I 10.1093/nar/gkab382 34019663 8265181
D. Steverding L. Troeberg 100 years since the publication of the suramin formula Parasitology Research 2023 123 1 11 10.1007/s00436-023-08027-7 38057659
M. Thiel N. Benaiche M. Martin S. Franceschini R. Van Oirbeek B. Govaerts limpca: An R package for the linear modeling of high-dimensional designed data based on ASCA/APCA family of methods Journal of Chemometrics 2023 37 7 e3482 1:CAS:528:DC%2BB3sXpt1KmsLo%3D 10.1002/cem.3482
M. Thiel B. Féraud B. Govaerts ASCA+ and APCA+: Extensions of ASCA and APCA in the analysis of unbalanced multifactorial designs: Analyzing unbalanced multifactorial designs with ASCA+ and APCA+ Journal of Chemometrics 2017 31 6 e2895 1:CAS:528:DC%2BC2sXhtVWltrvM 10.1002/cem.2895
I.M. Vincent M.P. Barrett Metabolomic-based strategies for anti-parasite drug discovery Journal of Biomolecular Screening 2015 20 1 44 55 1:CAS:528:DC%2BC2MXptlKgtA%3D%3D 10.1177/1087057114551519 25281738
N. Wiedemar D.A. Hauser P. Mäser 100 Years of Suramin Antimicrobial Agents and Chemotherapy 2020 10.1128/AAC.01168-19 31844000 7038244
E.A. Wiemer P.A. Michels F.R. Opperdoes The inhibition of pyruvate transport across the plasma membrane of the bloodstream form of Trypanosoma brucei and its metabolic implications The Biochemical Journal 1995 312 Pt 2 479 484 1:CAS:528:DyaK2MXpvVensL4%3D 10.1042/bj3120479 8526859 1136287
M. Willson M. Callens D.A. Kuntz J. Perié F.R. Opperdoes Synthesis and activity of inhibitors highly specific for the glycolytic enzymes from Trypanosoma brucei Molecular and Biochemical Parasitology 1993 59 2 201 210 1:CAS:528:DyaK2cXis1Whtw%3D%3D 10.1016/0166-6851(93)90218-m 8341319
Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., Fung, C., Nikolai, L., Lewis, M., Coutouly, M.-A., Forsythe, I., Tang, P., Shrivastava, S., Jeroncic, K., Stothard, P., … Querengesser, L. (2007). HMDB: The Human Metabolome Database. Nucleic Acids Research, 35 (Database issue), D521–526. https://doi.org/10.1093/nar/gkl923
D.S. Wishart Computational approaches to metabolomics Methods in Molecular Biology (Clifton, N.J.) 2010 593 283 313 1:CAS:528:DC%2BC3cXnvFWntrw%3D 10.1007/978-1-60327-194-3_14 19957155
A. Zíková Z. Verner A. Nenarokova P.A.M. Michels J. Lukeš A paradigm shift: The mitoproteomes of procyclic and bloodstream Trypanosoma brucei are comparably complex PLoS Pathogens 2017 13 12 e1006679 1:CAS:528:DC%2BC1cXhsFamu7vE 10.1371/journal.ppat.1006679 29267392 5739487
M. Zoltner G.D. Campagnaro G. Taleva A. Burrell M. Cerone K.-F. Leung F. Achcar D. Horn S. Vaughan C. Gadelha A. Zíková M.P. Barrett H.P. de Koning M.C. Field Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes Journal of Biological Chemistry 2020 10.1074/jbc.RA120.012355 32354742 7294092
M. Zoltner K.F. Leung S. Alsford D. Horn M.C. Field Modulation of the surface proteome through multiple ubiquitylation pathways in African trypanosomes PLoS Pathogens 2015 11 10 e1005236 1:CAS:528:DC%2BC28XitFKkuro%3D 10.1371/journal.ppat.1005236 26492041 4619645